Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Wang Qunbin: Innovation-Driven, Fosun's Path to Globalization 2025-10-17 11:17
Clarity signs copper-67 Supply Agreement with Nusano 2025-10-16 21:04
Cell Publishes Breakthrough Research Results of IASO Bio's Anti-BCMA CAR-T Equecabtagene Autoleucel in Autoimmune Disease Multiple Sclerosis 2025-10-16 20:45
Unixell Biotech reported a case study of UX-DA001, an iPSC-derived autologous cell therapy for Parkinson Diseases at MDS Congress 2025 2025-10-16 20:35
HARMONi-6 Phase III Study of Ivonescimab Accepted by The Lancet and Selected for ESMO 2025 LBA Presentation 2025-10-16 12:15
Gene Solutions Brings Insights on Advances in MRD and Multi-Omics Technologies to the Singapore Society of Oncology Annual Scientific Meeting 2025 2025-10-16 10:30
Jacobio Pharma Announces Strategic Partnership with Oceanpine Capital to Focus on Core Oncology Pipeline 2025-10-15 23:05
Nona Biosciences Appoints Dr. Di Hong as Chief Executive Officer to Drive Technology Innovation and Strategic Growth 2025-10-15 08:00
Mabwell Announces Latest Clinical Results of Novel B7-H3-Targeting ADC 7MW3711 to Be Presented at 2025 ESMO Congress 2025-10-15 00:00
Co-PSMA trial achieves primary endpoint 2025-10-14 21:03
Kyoto University Engineering Ph.D. Team Achieves Technology Transformation in Chengdu; LivingPhoenix's Biomimetic Collagen Rated "International Leading-Edge" 2025-10-14 20:30
Mabwell's CDH17-targeting ADC 7MW4911 Receives IND Clearance from NMPA 2025-10-14 20:00
Clover Announces Positive Phase I Clinical Data for RSV-hMPV-PIV3 Combination Vaccines and for RSV Re-Vaccination in Older Adults 2025-10-14 18:18
Ascletis Completes Denifanstat (ASC40) Pre-NDA Consultation with China National Medical Products Administration 2025-10-14 18:00
Telix Reports US$206M Revenue, FY 2025 Guidance Upgraded 2025-10-14 14:59
Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) Presented Preclinical Data on GNTbm-TKI, a Novel Multi-tyrosine Kinase Inhibitor with Potent Immune Activation, at the 2025 ESMO Annual Meeting 2025-10-14 14:26
2025 ACR Abstract Released! Exciting Data from Telitacicept's Phase III Clinical Study in Sjögren's Syndrome in China 2025-10-14 13:44
Everest Medicines Announces First Patient Enrolled in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14 2025-10-14 12:13
Thousand Oaks Biologics Shanghai ADC Site receives EU QP Declaration 2025-10-13 20:00
Chiron Medical Launches "Early Check, Early Hope" Campaign, Embracing Pink for Breast Cancer Awareness 2025-10-13 19:46
1 12 13 14 15 16 481